When.com Web Search

  1. Ads

    related to: breast cancer cell cycle

Search results

  1. Results From The WOW.Com Content Network
  2. CDKN1B - Wikipedia

    en.wikipedia.org/wiki/CDKN1B

    In hepatocellular carcinoma cells p27 co-localizes with actin fibers to act on GTPase Rac and induce cell migration. [22] In breast cancer cytoplasmic p27 reduced RHOA activity which increased a cell's propensity for motility. [23] This role for p27 may indicate why cancer cells rarely fully inactivate or delete p27.

  3. List of breast cancer cell lines - Wikipedia

    en.wikipedia.org/wiki/List_of_breast_cancer_cell...

    Scientists study the behaviour of isolated cells grown in the laboratory for insights into how cells function in the body in health and disease. Experiments using cell culture are used for developing new diagnostic tests and new treatments for diseases. This is a list of major breast cancer cell lines that are primarily used in breast cancer ...

  4. MDA-MB-453 - Wikipedia

    en.wikipedia.org/wiki/MDA-MB-453

    The cell line is a great model for breast cancer cells because the cells proliferate at a fast rate and is stimulated by androgens, but inhibited by progesterone, estrogen, and Her-2 receptors. The specific mutation that contributes to the cell cancer line is a glutamate to histidine change found on exon 7; more specifically, the amino acid 865.

  5. Breast cancer - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer

    The first breast cancer cell line described, BT-20, was established in 1958. Since then, and despite sustained work in this area, the number of permanent lines obtained has been strikingly low (about 100). Indeed, attempts to culture breast cancer cell lines from primary tumors have been largely unsuccessful.

  6. Cyclin-dependent kinase 7 - Wikipedia

    en.wikipedia.org/wiki/Cyclin-dependent_kinase_7

    Cells from breast cancer tumors were found to have elevated levels of CDK7 and Cyclin H when compared to normal breast cells. It was also found that the higher levels were generally found in ER-positive breast cancer. Together, these findings indicate that CDK7 therapy might make sense for some breast cancer patients. [7]

  7. CHEK2 - Wikipedia

    en.wikipedia.org/wiki/CHEK2

    The estimated fraction of breast cancer attributed to this variant is reported to be around 1.2% in the US. [ 8 ] Two more CHEK2 gene mutations, CHEK2*S428F, an amino-acid substitution to the kinase domain in exon 11 and CHEK2*P85L, an amino-acid substitution in the N-terminal region (exon 1) have been found in the Ashkenazi Jewish population ...

  8. MDA-MB231 - Wikipedia

    en.wikipedia.org/wiki/MDA-MB231

    [3] [4] In addition, this cell line has a low expression of the Ki-67 proliferation marker, down regulation of claudin-3 and claudin-4, enrichment for markers associated with the epithelial-mesenchymal transition and the CD44+ CD24-/low phenotype associated with breast cancer stem cells and increased metastasis, [5] [6] [7] and is a mutant in ...

  9. Ki-67 (protein) - Wikipedia

    en.wikipedia.org/wiki/Ki-67_(protein)

    Ki-67 is an excellent marker to determine the growth fraction of a given cell population. The fraction of Ki-67-positive tumor cells (the Ki-67 labeling index) is often correlated with the clinical course of cancer. The best-studied examples in this context are prostate, brain and breast carcinomas, as well as nephroblastoma and neuroendocrine ...